Evidence map›Paper›PMID 20230352›Full record

ReviewThe Medical journal of Australia2010

Invited editorial presents an accurate summary of the results of two randomised placebo-controlled trials of vertebroplasty.

Rachelle Buchbinder, Richard H Osborne, David Kallmes

Abstract readReviewComment
In one paragraph

Review in The Medical journal of Australia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Continuing conservative care versus crossover to radiofrequency kyphoplasty: a comparative effectiveness study on the treatment of vertebral body fractures.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2012
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Rachelle BuchbinderMonash Department of Clinical Epidemiology, Cabrini Hospital, Melbourne, Victoria. rachelle.buchbinder@med.monash.edu.au
Richard H Osborne
David Kallmes

Funding

SHAM-CONTROLLED TRIAL OF PERCUTANEOUS VERTEBROPLASTYR01AR049373 · NIAMS · MAYO CLINIC ROCHESTER · PI KALLMES, DAVID F · 2002 to 2008
$1.8M
NIAMS NIH HHS R01 AR049373NIAMS NIH HHS R01 AR 49373
6 · The paper itself

Abstract

Our recent editorial in the Journal presents an accurate summary of our two randomised trials of vertebroplasty, which found no benefit of vertebroplasty over placebo. Participants in both trials are representative of patients seen in clinical practice and who would qualify for government-subsidised funding of vertebroplasty in Australia. Clinical experience and previous published literature are likely to have overestimated the treatment benefit of vertebroplasty for many reasons. This is why randomised placebo-controlled trials are required to determine the efficacy of treatment interventions, particularly when the condition being treated is self-limiting and the primary end point is improvement of symptoms. Based on the best evidence currently available, the routine use of vertebroplasty outside of the research setting for painful osteoporotic vertebral fractures appears unjustified.

Indexed as

Periodicals as TopicRandomized Controlled Trials as TopicAustraliaHumansOsteoporosisOutcome Assessment, Health CarePatient SelectionReproducibility of ResultsSelection BiasSpinal FracturesVertebroplasty

Identifiers

PMID20230352
PMCPMC3935517

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.